World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 May 2023
Main ID:  RBR-88jb56
Date of registration: 26/01/2018
Prospective Registration: No
Primary sponsor: Universidade Federal de Ciências da Saúde de Porto Alegre
Public title: Interventions to hypertension control
Scientific title: Factors associated with no control of hypertension and effectiveness of individual interventions and group for the promotion of disease control
Date of first enrolment: 10/01/2016
Target sample size:
Recruitment status: Recruiting
URL:  http://ensaiosclinicos.gov.br/rg/RBR-88jb56
Study type:  Intervention
Study design:  Clinical trial, paralel, with three arms, open, randomized control, prospective.  
Phase:  N/A
Countries of recruitment
Brazil
Contacts
Name: Adriane Isabel   Rohden
Address:  Sarmento Leite, 245 90050-170 Porto Alegre Brazil
Telephone: +55 (51) 9857 5662
Email: adrianeisabel@gmail.com
Affiliation:  Universidade Federal de Ciências da Saúde de Porto Alegre
Name: Carine Raquel   Blatt
Address:  Sarmento Leite, 245 90050-170 Porto Alegre Brazil
Telephone: +55 (51) 9833 8000
Email: carine.blatt@gmail.com
Affiliation:  Universidade Federal de Ciências da Saúde de Porto Alegre
Key inclusion & exclusion criteria
Inclusion criteria: Hypertension patients with more than 18 years old and uncontroll hypertension (blood pression rate more that 140/90 mmHg) and participed of transversal study.
Exclusion criteria: Patients with secundary hypertension. Institutionalized patients, with mental illness or disabling chronic illness or a life expectancy of less than one year.

Age minimum: 18Y
Age maximum: 90Y
Gender: -
Health Condition(s) or Problem(s) studied
Hypertension
Intervention(s)
N04.452.758.244
Behavioural
F02.784.176.279.500
Patients without hypertension control will be aleatorized randomized into three groups of 130 patients to receive three interventions: individual counseling (CONSULTA), group monitoring (GROUP) and control (CONTROL). Patients included in the GROUP will have meetings biweekly during three months, with predefined themes as the needs of patients. These groups will last for a minimum 1 hour and maximum of 3 hours and will have a maximum of 20 participants.
Patients included in the CONSULTA will be done monthly consultation with a time of 15-60 min for three months, performed by students (pharmacy, psychology, nursing, medicines and nutrition) under supervision of an assistent professor.
Patients included in the CONTROL will have usual follow up and blood pressure mesure after 4 months.
Primary Outcome(s)
Mean reduction of blood pressure in mmHg calculated by Systolic and Diastolic Blood Pressure mean comparing between baseline time and endpoint.
Secondary Outcome(s)
Treatment Adherence evaluated by Morisky Green scale at the baseline and endpoint.

Secondary ID(s)
Source(s) of Monetary Support
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Universidade Federal de Ciências da Saúde de Porto Alegre
Secondary Sponsor(s)
Universidade Federal de Ciências da Saúde de Porto Alegre
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history